Negotiations between the Trump administration and pharmaceutical companies on lowering U.S. prescription drug prices to match those of other countries appear to be ongoing despite the deadline passing.

President Donald Trump gave 17 major pharmaceutical companies a Monday deadline to begin voluntarily implementing a “most favored nation” pricing program for prescription drugs, which would bring U.S. drug prices in line with those of other developed nations.

Recommended Stories

GOP nears schism over hepatitis B vaccinations

Thune dismisses Democrats' demand to reach Obamacare subsidies deal before shutdown

Wisconsin Planned Parenthood to stop abortions next week to avoid funding cuts

Several pharmaceutical companies told the Washington Examiner on Monday that they are still ne

See Full Page